Glenn-Milo Santos, PhD, MPH

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentCommunity Health Systems
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San FranciscoPh.D.Department of Epidemiology and Biostatistics
    University of California, BerkeleyM.P.H.Division of Epidemiology, School of Public Health
    Carleton CollegeB.A. Biology
    Collapse Awards and Honors
    National Institute of Health, Office of the Director2014National Institute of Health Director’s Early Independence Award
    University of California Office of the President2013University of California President’s Dissertation-Year Fellowship Program Award
    National Institutes of Health2012National Institute on Drug Abuse Dissertation Research Award
    Graduate Division, University of California, San Francisco2012Graduate Research Mentorship Fellowship
    2011 National HIV Prevention Conference, Centers For Disease Control and Prevention2011Young Innovator in HIV Research
    6th IAS Conference On HIV Pathogenesis, Treatment and Prevention 2011Gold Star Scientific Merit Award
    San Francisco Health Commission2005Youth Health Advisor
    Carleton College2003Freeman Foundation Research Fellowship

    Collapse Overview 
    Collapse Overview
    My research foci involve the development of pharmacologic and behavioral interventions to reduce substance use and HIV-related sexual risk behaviors among key populations at risk for HIV, including men who have sex with men, transgender individuals, and people who use drugs. In addition, I am interested in evaluating the impact of alcohol and substance use on HIV treatment and care among HIV-positive individuals.

    Collapse Research 
    Collapse Research Activities and Funding
    The A-HACK Project: Addressing Heavy Alcohol Consumption with Kudzu
    NIH/NIAAA R01AA025930-01A1Sep 20, 2018 - Sep 19, 2023
    Role: Principal Investigator
    Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
    NIH R01DA045690Jun 15, 2018 - Mar 31, 2023
    Role: Co-Investigator
    The SUPrEME Study: Substance Use and PrEP adherance among Men who have sex with Men
    UCSF – Center for AIDS Research (CFAR) Mentored Scientist Award Program in HIV/AIDSSep 1, 2017 - Aug 31, 2019
    Role: Principal Investigator
    NIH 1R34DA042161-01A1May 1, 2017 - Apr 30, 2020
    Role: Principal Investigator
    Risk Behavior Changes in the Era of Pre-exposure Prophylaxis (PrEP) for HIV.
    NIH F31NR016179Sep 30, 2016 - Jul 29, 2018
    Role: Primary Mentor
    Substance use outcomes of opioid dose reduction and discontinuation
    NIH U01CE002793Sep 1, 2016 - Aug 31, 2018
    Role: Co-Investigator
    Cohort Study of Opioids, Pain, and Safety in an era of Changing Policy (COPING)
    NIH R01DA040189Aug 15, 2016 - May 31, 2021
    Role: Co-Investigator
    The Transnational Cohort: global HIV epidemiology and prevention research for transwomen.
    NIH R01MD010678Sep 25, 2015 - Jun 30, 2020
    Role: Co-Investigator
    Hepatitis C Treatment As Prevention Pilot Study with Ledipasvir-Sofosbuvir Among People Actively Injecting Drugs (TasP-C Pilot)
    NIH R34DA039333Jul 15, 2015 - May 31, 2018
    Role: Co-Investigator
    START: Study of Trauma and Reduction of HIV Transmission
    NIH F31DA039056Jul 1, 2015 - Jun 30, 2018
    Role: Mentor
    The Better THAN Study: Targeting Heavy Alcohol with Naltrexone among MSM
    NIH DP5OD019809Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator
    An Assessment of Opioid Overdoses in San Francisco from 2010 through 2012
    NIH R03DA038084Jul 1, 2014 - Jun 30, 2016
    Role: Co-Investigator
    Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Nalo
    NIH R34DA037194Apr 1, 2014 - Mar 31, 2017
    Role: Co-Investigator
    Naloxone prescription for Opioid Safety Evaluation (NOSE)
    NIH R21DA036776Jul 15, 2013 - Jun 30, 2015
    Role: Co-Investigator
    Mirtazapine for the treatment of methamphetamine dependence among MSM with high-r
    NIH/NIDA R01DA034527Feb 1, 2013 - Jan 31, 2018
    Role: Co-Investigator
    Intermittent Naltrexone among Polysubstance Users
    NIH R36DA035109Sep 30, 2012 - Aug 31, 2014
    Role: Principal Investigator
    Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B
    NIH/NIDA R01DA031678Jun 1, 2011 - Jan 31, 2017
    Role: Co-Investigator
    Reducing HIV risk among episodic substance-using MSM
    NIH UR6PS000684Sep 30, 2007 - Sep 29, 2013
    Role: Epidemiologist
    Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors
    NIH R01DA023387Sep 28, 2007 - Jan 31, 2013
    Role: Epidemiologist
    Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM
    NIH R01DA022190Sep 30, 2006 - Jul 31, 2010
    Role: Epidemiologist
    Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors
    NIH R01DA022155Sep 1, 2006 - May 31, 2010
    Role: Epidemiologist
    Acceptability of pharmacologic treatment for methamphetamine dependence among MSM
    NIH R21DA021090Sep 29, 2005 - Aug 30, 2008
    Role: Epidemiologist

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hsiang E, Jennings D, Matheson T, Hern J, Euren J, Santos GM. Acceptability of pharmacotherapy for hazardous alcohol use among men who have sex with men: Findings from a qualitative study. Addict Behav Rep. 2018 Dec; 8:122-127. PMID: 30258972.
      View in: PubMed
    2. Santos GM, Rowe C, Hern J, Walker JE, Ali A, Ornelaz M, Prescott M, Coffin P, McFarland W, Raymond HF. Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco. PLoS One. 2018; 13(8):e0202170. PMID: 30118495.
      View in: PubMed
    3. Ayala G, Santos GM, Arreola S, Garner A, Makofane K, Howell S. Blue-Ribbon Boys: factors associated with PrEP use, ART use and undetectable viral load among gay app users across six regions of the world. J Int AIDS Soc. 2018 Jul; 21 Suppl 5:e25130. PMID: 30033536.
      View in: PubMed
    4. Rowe C, Wheeler E, Vittinghoff E, Santos GM, Behar E, Coffin PO. Quantity fluctuations of illicitly used opioids and overdose risk. Int J Drug Policy. 2018 May 25; 58:64-70. PMID: 29807248.
      View in: PubMed
    5. Turner C, Chandrakumar D, Rowe C, Santos GM, Riley ED, Coffin PO. Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend. 2018 Feb 21; 185:305-312. PMID: 29486419.
      View in: PubMed
    6. Rowe C, Vittinghoff E, Colfax G, Coffin PO, Santos GM. Correlates of Validity of Self-Reported Methamphetamine Use Among a Sample of Dependent Adults. Subst Use Misuse. 2018 Feb 20; 1-14. PMID: 29461134.
      View in: PubMed
    7. Santa Maria D, Padhye N, Yang Y, Gallardo K, Santos GM, Jung J, Businelle M. Drug use patterns and predictors among homeless youth: results of an ecological momentary assessment. Am J Drug Alcohol Abuse. 2017 Dec 29; 1-10. PMID: 29286835.
      View in: PubMed
    8. Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO. Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study. J Subst Abuse Treat. 2017 Nov 08. PMID: 29150316.
      View in: PubMed
    9. Coffin PO, Santos GM, Matheson T, Behar E, Rowe C, Rubin T, Silvis J, Vittinghoff E. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLoS One. 2017; 12(10):e0183354. PMID: 29049282.
      View in: PubMed
    10. Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. Addiction. 2018 Feb; 113(2):268-278. PMID: 28734107.
      View in: PubMed
    11. Guigayoma J, Chen YH, Snowden JM, Santos GM, Hecht J, Raymond HF. Self-Perceived Viral Load and Sexual Risk Behavior Among Known HIV-Positive MSM in San Francisco, 2014. J Acquir Immune Defic Syndr. 2017 07 01; 75 Suppl 3:S309-S315. PMID: 28604432.
      View in: PubMed
    12. Brown RE, Turner C, Hern J, Santos GM. Partner-level substance use associated with increased sexual risk behaviors among men who have sex with men in San Francisco, CA. Drug Alcohol Depend. 2017 07 01; 176:176-180. PMID: 28549302.
      View in: PubMed
    13. Rowe C, Vittinghoff E, Santos GM, Behar E, Turner C, Coffin PO. Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department. Acad Emerg Med. 2017 Apr; 24(4):475-483. PMID: 27763703.
      View in: PubMed
    14. Turner CM, Santos GM, Arayasirikul S, Wilson EC. Brief Report: Psychosocial Predictors of Engagement in Sexual Risk Behavior Among Trans*female Youth Aged 16-24 Years in San Francisco. J Acquir Immune Defic Syndr. 2017 03 01; 74(3):258-264. PMID: 27861237.
      View in: PubMed
    15. Behar E, Rowe C, Santos GM, Santos N, Coffin PO. Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco. Fam Med. 2017 Feb; 49(2):122-126. PMID: 28218937.
      View in: PubMed
    16. Flores JM, Santos GM, Makofane K, Arreola S, Ayala G. Availability and Use of Substance Abuse Treatment Programs Among Substance-Using Men Who Have Sex With Men Worldwide. Subst Use Misuse. 2017 Apr 16; 52(5):666-673. PMID: 28139146.
      View in: PubMed
    17. Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM. Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco. J Subst Abuse Treat. 2017 04; 75:43-48. PMID: 28237053.
      View in: PubMed
    18. Rowe C, Santos GM, Raymond HF, Coffin PO. Social mixing and correlates of injection frequency among opioid use partnerships. Int J Drug Policy. 2017 03; 41:80-88. PMID: 28113118.
      View in: PubMed
    19. Jain J, Santos GM, Scheer S, Gibson S, Crouch PC, Kohn R, Chang W, Carrico AW. Rates and Correlates of Syphilis Reinfection in Men Who Have Sex with Men. LGBT Health. 2017 Jun; 4(3):232-236. PMID: 27991843.
      View in: PubMed
    20. Ayala G, Santos GM. Will the global HIV response fail gay and bisexual men and other men who have sex with men? J Int AIDS Soc. 2016; 19(1):21098. PMID: 27876454.
      View in: PubMed
    21. Behar E, Rowe C, Santos GM, Coffa D, Turner C, Santos NC, Coffin PO. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain. J Gen Intern Med. 2017 Mar; 32(3):291-295. PMID: 27815762.
      View in: PubMed
    22. Bender MS, Santos GM, Villanueva C, Arai S. Development of a Mobile Phone-Based Weight Loss Lifestyle Intervention for Filipino Americans with Type 2 Diabetes: Protocol and Early Results From the PilAm Go4Health Randomized Controlled Trial. JMIR Res Protoc. 2016 Sep 08; 5(3):e178. PMID: 27608829.
      View in: PubMed
    23. Behar E, Rowe C, Santos GM, Murphy S, Coffin PO. Primary Care Patient Experience with Naloxone Prescription. Ann Fam Med. 2016 09; 14(5):431-6. PMID: 27621159.
      View in: PubMed
    24. Scheim AI, Santos GM, Arreola S, Makofane K, Do TD, Hebert P, Thomann M, Ayala G. Inequities in access to HIV prevention services for transgender men: results of a global survey of men who have sex with men. J Int AIDS Soc. 2016; 19(3 Suppl 2):20779. PMID: 27431466.
      View in: PubMed
    25. Coffin PO, Behar E, Rowe C, Santos GM, Coffa D, Bald M, Vittinghoff E. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016 Aug 16; 165(4):245-52. PMID: 27366987.
      View in: PubMed
    26. Rowe C, Liou T, Vittinghoff E, Coffin PO, Santos GM. Binge drinking concurrent with anal intercourse and condom use among men who have sex with men. AIDS Care. 2016 Dec; 28(12):1566-1570. PMID: 27241085.
      View in: PubMed
    27. Rowe C, Hern J, DeMartini A, Jennings D, Sommers M, Walker J, Santos GM. Concordance of Text Message Ecological Momentary Assessment and Retrospective Survey Data Among Substance-Using Men Who Have Sex With Men: A Secondary Analysis of a Randomized Controlled Trial. JMIR Mhealth Uhealth. 2016 May 26; 4(2):e44. PMID: 27230545; PMCID: PMC4901189.
    28. Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):21-30. PMID: 26674372; PMCID: PMC4837026 [Available on 05/01/17].
    29. Rowe C, Matheson T, Das M, DeMicco E, Herbst JH, Coffin PO, Santos GM. Correlates of recent HIV testing among substance-using men who have sex with men. Int J STD AIDS. 2017 05; 28(6):594-601. PMID: 27000299.
      View in: PubMed
    30. Santos GM, Makofane K, Arreola S, Do T, Ayala G. Reductions in access to HIV prevention and care services are associated with arrest and convictions in a global survey of men who have sex with men. Sex Transm Infect. 2017 Feb; 93(1):62-64. PMID: 26944344.
      View in: PubMed
    31. Raymond HF, Scheer S, Santos GM, McFarland W. Examining progress toward the UNAIDS 90-90-90 framework among men who have sex with men, San Francisco, 2014. AIDS Care. 2016 Sep; 28(9):1177-80. PMID: 26916991.
      View in: PubMed
    32. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. J Urban Health. 2016 Feb; 93(1):117-30. PMID: 26800987; PMCID: PMC4794468 [Available on 02/01/17].
    33. Rowe C, Santos GM, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016 Feb 01; 159:234-9. PMID: 26754425; PMCID: PMC4734628 [Available on 02/01/17].
    34. Cohen JK, Santos GM, Moss NJ, Coffin PO, Block N, Klausner JD. Regular clinic attendance in two large San Francisco HIV primary care settings. AIDS Care. 2016; 28(5):579-84. PMID: 26654093.
      View in: PubMed
    35. de Haan G, Santos GM, Arayasirikul S, Raymond HF. Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco. LGBT Health. 2015 Dec; 2(4):313-23. PMID: 26788772.
      View in: PubMed
    36. Santos GM, Jin H, Raymond HF. Pervasive Heavy Alcohol Use and Correlates of Increasing Levels of Binge Drinking among Men Who Have Sex with Men, San Francisco, 2011. J Urban Health. 2015 Aug; 92(4):687-700. PMID: 25895622; PMCID: PMC4524848.
    37. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015 Aug; 110(8):1301-10. PMID: 25917125; PMCID: PMC4503489.
    38. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities. J Urban Health. 2015 Aug; 92(4):758-72. PMID: 26077643; PMCID: PMC4524842.
    39. Asiimwe SB, Fatch R, Emenyonu NI, Muyindike WR, Kekibiina A, Santos GM, Greenfield TK, Hahn JA. Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa. Alcohol Clin Exp Res. 2015 Aug; 39(8):1518-27. PMID: 26148140; PMCID: PMC4515166.
    40. Coffin PO, Rowe C, Santos GM. Novel interventions to prevent HIV and HCV among persons who inject drugs. Curr HIV/AIDS Rep. 2015 Mar; 12(1):145-63. PMID: 25589380.
      View in: PubMed
    41. Scheim AI, Arreola S, Do T, Makofane K, Santos GM, Thomann M, Wilson PA, Ayala G. Potential for conceptual bias in studies of racial disparities in HIV infection. J Acquir Immune Defic Syndr. 2015 Mar 01; 68(3):e42-3. PMID: 25296101.
      View in: PubMed
    42. Arreola S, Santos GM, Beck J, Sundararaj M, Wilson PA, Hebert P, Makofane K, Do TD, Ayala G. Sexual stigma, criminalization, investment, and access to HIV services among men who have sex with men worldwide. AIDS Behav. 2015 Feb; 19(2):227-34. PMID: 25086670.
      View in: PubMed
    43. Behar E, Santos GM, Wheeler E, Rowe C, Coffin PO. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015 Mar 01; 148:209-12. PMID: 25595053.
      View in: PubMed
    44. Rowe C, Santos GM, McFarland W, Wilson EC. Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015 Feb 01; 147:160-6. PMID: 25548025; PMCID: PMC4297727.
    45. Ayala G, Makofane K, Santos GM, Arreola S, Hebert P, Thomann M, Wilson P, Beck J, Do TD.HIV Treatment Cascades that Leak: Correlates of Drop-off from the HIV Care Continuum among Men who have Sex with Men Worldwide. Journal of AIDS & Clinical Research. 2014.
    46. Wilson EC, Santos GM, Raymond HF. Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010. BMC Infect Dis. 2014 Aug 06; 14:430. PMID: 25100405; PMCID: PMC4132923.
    47. Hermanstyne KA, Santos GM, Vittinghoff E, Santos D, Colfax G, Coffin P. Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses. Drug Alcohol Depend. 2014 Oct 01; 143:277-80. PMID: 25156227; PMCID: PMC4170077.
    48. Hanckel B, Garcia L, Santos GM, Manalastas EJ.Assessing needs and capabilities: Towards an ICT resource to support HIV-positive gay men and other MSM in Southeast Asia. Digital Culture & Education. 2014; 6(2014).
    49. Coffin PO, Santos GM, Colfax G, Das M, Matheson T, DeMicco E, Dilley J, Vittinghoff E, Raiford JL, Carry M, Herbst JH. Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trial. AIDS Behav. 2014 Jul; 18(7):1390-400. PMID: 24510401; PMCID: PMC4655874.
    50. Knight KR, Das M, DeMicco E, Raiford JL, Matheson T, Shook A, Antunez E, Santos GM, Dadasovich R, Dilley JW, Colfax GN, Herbst JH. A roadmap for adapting an evidence-based HIV prevention intervention: personal cognitive counseling (PCC) for episodic substance-using men who have sex with men. Prev Sci. 2014 Jun; 15(3):364-75. PMID: 23412947; PMCID: PMC4674782.
    51. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. A closer look at hepatitis C clearance in HIV controllers: a response. AIDS. 2014 May 15; 28(8):1241-2. PMID: 25028914; PMCID: PMC4214212.
    52. Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014 Aug; 90(5):430-3. PMID: 24714446.
      View in: PubMed
    53. Santos GM, Rapues J, Wilson EC, Macias O, Packer T, Colfax G, Raymond HF. Alcohol and substance use among transgender women in San Francisco: prevalence and association with human immunodeficiency virus infection. Drug Alcohol Rev. 2014 May; 33(3):287-95. PMID: 24628655.
      View in: PubMed
    54. Santos GM, Coffin PO, Vittinghoff E, DeMicco E, Das M, Matheson T, Raiford JL, Carry M, Colfax G, Herbst JH, Dilley JW. Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with men. Drug Alcohol Depend. 2014 May 01; 138:234-9. PMID: 24641808; PMCID: PMC4673670.
    55. Pyun T, Santos GM, Arreola S, Do T, Hebert P, Beck J, Makofane K, Wilson PA, Ayala G. Internalized homophobia and reduced HIV testing among men who have sex with men in China. Asia Pac J Public Health. 2014 Mar; 26(2):118-25. PMID: 24554493.
      View in: PubMed
    56. Santos GM, Do T, Beck J, Makofane K, Arreola S, Pyun T, Hebert P, Wilson PA, Ayala G. Syndemic conditions associated with increased HIV risk in a global sample of men who have sex with men. Sex Transm Infect. 2014 May; 90(3):250-3. PMID: 24431183.
      View in: PubMed
    57. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6. PMID: 23939233; PMCID: PMC4125012.
    58. Santos GM, Emenyonu NI, Bajunirwe F, Rain Mocello A, Martin JN, Vittinghoff E, Bangsberg DR, Hahn JA. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda. Drug Alcohol Depend. 2014 Jan 01; 134:151-157. PMID: 24169501; PMCID: PMC3885244.
    59. Santos GM, Beck J, Wilson PA, Hebert P, Makofane K, Pyun T, Do T, Arreola S, Ayala G. Homophobia as a barrier to HIV prevention service access for young men who have sex with men. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):e167-70. PMID: 24135782.
      View in: PubMed
    60. Santos GM, Coffin PO, Das M, Matheson T, DeMicco E, Raiford JL, Vittinghoff E, Dilley JW, Colfax G, Herbst JH. Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco. J Acquir Immune Defic Syndr. 2013 Aug 01; 63(4):540-4. PMID: 23572012; PMCID: PMC4671496.
    61. Ayala G, Makofane K, Santos GM, Beck J, Do TD, Hebert P, Wilson PA, Pyun T, Arreola S. Access to Basic HIV-Related Services and PrEP Acceptability among Men Who Have sex with Men Worldwide: Barriers, Facilitators, and Implications for Combination Prevention. J Sex Transm Dis. 2013; 2013:953123. PMID: 26316968; PMCID: PMC4437423.
    62. Coffin PO, Santos GM, Das M, Santos DM, Huffaker S, Matheson T, Gasper J, Vittinghoff E, Colfax GN. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction. 2013 Apr; 108(4):751-61. PMID: 23186131; PMCID: PMC3602333.
    63. Colfax GN, Santos GM, Das M, Santos DM, Matheson T, Gasper J, Shoptaw S, Vittinghoff E. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry. 2011 Nov; 68(11):1168-75. PMID: 22065532; PMCID: PMC3437988.
    64. Santos GM, Das M, Colfax GN. Interventions for non-injection substance use among US men who have sex with men: what is needed. AIDS Behav. 2011 Apr; 15 Suppl 1:S51-6. PMID: 21404011; PMCID: PMC3064889.
    65. Colfax G, Santos GM, Chu P, Vittinghoff E, Pluddemann A, Kumar S, Hart C. Amphetamine-group substances and HIV. Lancet. 2010 Aug 07; 376(9739):458-74. PMID: 20650520.
      View in: PubMed
    66. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010 Jun 10; 5(6):e11068. PMID: 20548786; PMCID: PMC2883572.
    67. Das M, Santos D, Matheson T, Santos GM, Chu P, Vittinghoff E, Shoptaw S, Colfax GN. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. AIDS. 2010 Apr 24; 24(7):991-1000. PMID: 20397286; PMCID: PMC3619723.
    Glenn-Milo's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.